Matches in Wikidata for { <http://www.wikidata.org/entity/Q66040813> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q66040813 description "clinical trial" @default.
- Q66040813 description "ensayu clínicu" @default.
- Q66040813 description "klinisch onderzoek" @default.
- Q66040813 description "клінічне випробування" @default.
- Q66040813 description "կլինիկական փորձարկում" @default.
- Q66040813 name "Addition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment Regimen" @default.
- Q66040813 name "Addition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment Regimen" @default.
- Q66040813 type Item @default.
- Q66040813 label "Addition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment Regimen" @default.
- Q66040813 label "Addition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment Regimen" @default.
- Q66040813 prefLabel "Addition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment Regimen" @default.
- Q66040813 prefLabel "Addition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment Regimen" @default.
- Q66040813 P1132 Q66040813-12928B67-2D8B-4DA3-BDB2-9055A59D632D @default.
- Q66040813 P131 Q66040813-2AEC7D98-D9F2-4108-B421-E7CE02B51C87 @default.
- Q66040813 P1476 Q66040813-C8EEE6D7-CD86-402A-B347-34E95C55E90A @default.
- Q66040813 P17 Q66040813-B5B62A02-8590-47E7-ACE2-072DD50E99C8 @default.
- Q66040813 P2899 Q66040813-0B3E6638-D102-47B6-8890-F80A70B2DBC5 @default.
- Q66040813 P3098 Q66040813-4690D5E7-51C2-4CB5-A255-77CCC96A1FF5 @default.
- Q66040813 P31 Q66040813-B88706FF-5DBB-41BB-8D22-58300E9B4CE9 @default.
- Q66040813 P4844 Q66040813-3F8B6497-7E0F-4C0A-B103-D3A904A845AF @default.
- Q66040813 P4844 Q66040813-A6A87D3F-5A08-4849-90B2-F142661B07A6 @default.
- Q66040813 P6099 Q66040813-CC21C6D6-E1CE-4E54-956E-420A17070044 @default.
- Q66040813 P6153 Q66040813-516E65EC-2B88-4A3E-BD0A-1D9869D90E01 @default.
- Q66040813 P6153 Q66040813-66691660-030C-4E86-8C4D-2DDEFE2BC08B @default.
- Q66040813 P6153 Q66040813-87221EDA-550F-4AD9-B07C-701C4AA70AC0 @default.
- Q66040813 P8363 Q66040813-65D02C43-93F1-4266-B196-9DA3E4265113 @default.
- Q66040813 P1132 "+444" @default.
- Q66040813 P131 Q1183 @default.
- Q66040813 P1476 "A Phase III Randomized, Controlled Trial of Efavirenz (EFV) or Nelfinavir (NFV) in Combination With Fixed-Dose Combination Lamivudine/Zidovudine (3TC/ZDV) and Indinavir (IDV) in HIV-Infected Subjects With Less Than or Equal to 200 CD4 Cells/mm3 or Greater Than or Equal to 80,000 HIV RNA Copies/ml in Plasma" @default.
- Q66040813 P17 Q30 @default.
- Q66040813 P2899 "+13" @default.
- Q66040813 P3098 "NCT00000903" @default.
- Q66040813 P31 Q30612 @default.
- Q66040813 P4844 Q198504 @default.
- Q66040813 P4844 Q425490 @default.
- Q66040813 P6099 Q42824827 @default.
- Q66040813 P6153 Q1468161 @default.
- Q66040813 P6153 Q193727 @default.
- Q66040813 P6153 Q309350 @default.
- Q66040813 P8363 Q78089383 @default.